• Home
  • News
  • Analysis
  •  
    Regions
    • Australasia
    • Southeast Asia
    • Greater China
    • North Asia
    • South Asia
    • North America
    • Europe
    • Central Asia
    • MENA
  •  
    Funds
    • LPs
    • Buyout
    • Growth
    • Venture
    • Renminbi
    • Secondary
    • Credit/Special Situations
    • Infrastructure
    • Real Estate
  •  
    Investments
    • Buyout
    • Growth
    • Early stage
    • PIPE
    • Credit
  •  
    Exits
    • IPO
    • Open market
    • Trade sale
    • Buyback
  •  
    Sectors
    • Consumer
    • Financials
    • Healthcare
    • Industrials
    • Infrastructure
    • Media
    • Technology
    • Real Estate
  • Events
  • Chinese edition
  • Data & Research
  • Weekly Digest
  • Newsletters
  • Sign in
  • Events
  • Sign in
    • You are currently accessing unquote.com via your Enterprise account.

      If you already have an account please use the link below to sign in.

      If you have any problems with your access or would like to request an individual access account please contact our customer service team.

      Phone: +44 (0)870 240 8859

      Email: customerservices@incisivemedia.com

      • Sign in
     
      • Saved articles
      • Newsletters
      • Account details
      • Contact support
      • Sign out
     
  • Follow us
    • RSS
    • Twitter
    • LinkedIn
    • Newsletters
  • Free Trial
  • Subscribe
  • Weekly Digest
  • Chinese edition
  • Data & Research
    • Latest Data & Research
      2023-china-216x305
      Regional Reports

      The reports review the year's local private equity and venture capital activity and are filled with up-to-date data and intelligence on fundraising, investments, exits and M&A. The regional reports also feature information on key companies.

      Read more
      2016-pevc-cover
      Industry Review

      Asian Private Equity and Venture Capital Review provides an independent overview of the private equity, venture capital and M&A activities in the Asia region. It delivers insights on investments made, capital raised, sector specific figures and more.

      Read more
      AVCJ Database

      AVCJ Database is the ultimate link between Asian dealmakers and those who provide advisory, financial, legal and technological services to the private equity, venture capital and M&A industries. It is packed with facts and figures on more than 153,000 companies and almost 117,000 transactions.

      Read more
AVCJ
AVCJ
  • Home
  • News
  • Analysis
  • Regions
  • Funds
  • Investments
  • Exits
  • Sectors
  • You are currently accessing unquote.com via your Enterprise account.

    If you already have an account please use the link below to sign in.

    If you have any problems with your access or would like to request an individual access account please contact our customer service team.

    Phone: +44 (0)870 240 8859

    Email: customerservices@incisivemedia.com

    • Sign in
 
    • Saved articles
    • Newsletters
    • Account details
    • Contact support
    • Sign out
 
AVCJ
  • Southeast Asia

Deal focus: Bringing specialization to healthcare

heart-healthcare
  • Justin Niessner
  • 14 July 2021
  • Tweet  
  • Facebook  
  • LinkedIn  
  • Google plus  
  • Save this article  
  • Send to  

TE Asia Healthcare Partners, a Southeast Asia-focused investor backed by TPG Capital, has launched a long-term plan to add much-needed cardiology hospitals to Indonesia’s healthcare mix

According to the World Health Organization, 79% of Indonesian males over 15 years old are smokers, and 25% of everyone aged 18 and above has elevated blood pressure. Cardiovascular diseases are the country’s leading killer, accounting for more than one-third of deaths. For investors interested in cardiovascular hospitals, this is the demand side of the equation, and it’s easy to understand.

The supply side is trickier. Hospitals are nothing without doctors and nurses, who are often relatively scarce in developing countries, especially in specialist areas. It takes 12-15 doctors to make a specialist hospital viable business, and Indonesia has not historically had enough talent to make this work. There are only three cardiologists per one million people, compared to 40 in Singapore and 60 in the US.

TE Asia Healthcare Partners, a Singapore-based platform backed by TPG Capital, sees this end of the equation turning around, however. This week, the firm acquired controlling stakes in two Jakarta area cardiology practices in a $50 million transaction alongside regional family office Altrui Investment Management. TE Asia and doctors at both practices will own 75%, with TE Asia being the majority shareholder. Altrui will own the remaining 25%.

“You do actually have enough doctors who are able to do this right now and are willing to come together. We see an interesting inflection point, where you have a new generation of doctors saying, ‘we should do this as a group and make it effective,’” says Eng Aik Meng, CEO of TE Asia, adding that his firm’s model of partnering with doctors as owners is a critical motivational factor.

“This means that they have a financial, emotional, and professional interest – all three. If doctors want it to work, they have to make sure that their colleagues do well and that the whole hospital does well. It’s no longer about being the solo independent contributor.”

Much of the thesis is about the rise of specialization. TE Asia believes it can achieve economic efficiencies in facilities that concentrate on one or two disciplines, despite the high cost of unusual equipment. Indonesia is seen as ready for this service, with rising insurance rates and patient sophistication, as well as growing exasperation about long wait times for specialized treatment at general hospitals.

There is also the idea that COVID-19 has lowered public appetite for large general hospitals, making smaller specialist operations more appealing. Perhaps most straightforwardly, the fact remains that the deadliest diseases cannot always be effectively treated by generalist practitioners using generalist equipment.

“Diseases and healthcare have become quite complex. You’re not going to have a one-doctor solution anymore, so we believe the solution is going to be group practices,” Eng says. “The days when you saw your friendly neighborhood doctor for everything from a headache to a cancer diagnosis are gone.”

The assets in question include Heartology Cardiovascular Centre, which began operations in September last year, having leased some space in Brawijaya Hospital. Heartology currently employs nine doctors and boasts Indonesia’s first true hybrid operating theater, which enables complex procedures. Most of the investment will be poured into Kebayoran, a greenfield development set to become a 44-bed facility with two cardiac catheterization labs by early 2023.

Both facilities will become the hub of a hub-and-spoke model, most likely featuring small clinics around the greater Jakarta area, where basic check-ups can be conducted. There is also potential for digital connectivity between facilities as a way of spreading a limited skills base over a wider service area.

TE Asia plans to build out the project in other cities, but the talent issue remains the recurring inhibitor. In Indonesia, as in many developing countries, the top talent tends to congregate in the capital city, leaving other urban areas wanting.

“We think some of the larger cities that have already established either teaching hospitals or medical universities could be attractive, but it will take time,” Eng says. “It takes 10 years to be a specialist after med school. It’s not going to be a quick turnaround.”

  • Tweet  
  • Facebook  
  • LinkedIn  
  • Google plus  
  • Save this article  
  • Send to  
  • Topics
  • Southeast Asia
  • Buyouts
  • Healthcare
  • Indonesia
  • TPG Capital

More on Southeast Asia

housing-house-home-mortgage
Singapore fintech start-up LXA gets $10m seed round
  • Southeast Asia
  • 10 Nov 2023
airport-travel
Asia’s LP landscape: North to south
  • LPs
  • 08 Nov 2023
singapore-harbor-cityscape-night
Reed Smith hires Sidley Austin's Asia fund formation leader
  • Southeast Asia
  • 02 Nov 2023
biotech-lab-healthcare-pharma-02
Polaris leads $27m round for Singapore's Engine Biosciences
  • Southeast Asia
  • 01 Nov 2023

Latest News

world-hands-globe-climate-esg
Asian GPs slow implementation of ESG policies - survey

Asia-based private equity firms are assigning more dedicated resources to environment, social, and governance (ESG) programmes, but policy changes have slowed in the past 12 months, in part due to concerns raised internally and by LPs, according to a...

  • GPs
  • 10 November 2023
housing-house-home-mortgage
Singapore fintech start-up LXA gets $10m seed round

New Enterprise Associates (NEA) has led a USD 10m seed round for Singapore’s LXA, a financial technology start-up launched by a former Asia senior executive at The Blackstone Group.

  • Southeast Asia
  • 10 November 2023
india-rupee-money-nbfc
India's InCred announces $60m round, claims unicorn status

Indian non-bank lender InCred Financial Services said it has received INR 5bn (USD 60m) at a valuation of at least USD 1bn from unnamed investors including “a global private equity fund.”

  • South Asia
  • 10 November 2023
roller-mark-luke-finn
Insight leads $50m round for Australia's Roller

Insight Partners has led a USD 50m round for Australia’s Roller, a venue management software provider specializing in family fun parks.

  • Australasia
  • 10 November 2023
Back to Top
  • About AVCJ
  • Advertise
  • Contacts
  • About ION Analytics
  • Terms of use
  • Privacy policy
  • Group disclaimer
  • RSS
  • Twitter
  • LinkedIn
  • Newsletters

© Merger Market

© Mergermarket Limited, 10 Queen Street Place, London EC4R 1BE - Company registration number 03879547

Digital publisher of the year 2010 & 2013

Digital publisher of the year 2010 & 2013